INV-311

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameINV-311
Drug Alias Namemyeloperoxidase inhibitors (InVasc Therapeutics)INV-300 series (InVasc)INV-311
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionMyeloperoxidase inhibitors
TargetsMyeloperoxidase
Therapy Area/IndicationsVasculitisMyocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInvasc Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInvasc Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsVasculitisMyocardial Infarction

Other Information

ATC CodeN/A
Related LinksN/A